BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 10358194)

  • 21. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
    Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
    Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct regulation of C3a-induced MCP-1/CCL2 and RANTES/CCL5 production in human mast cells by extracellular signal regulated kinase and PI3 kinase.
    Venkatesha RT; Berla Thangam E; Zaidi AK; Ali H
    Mol Immunol; 2005 Mar; 42(5):581-7. PubMed ID: 15607817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cytokines by human astrocytomas following stimulation by C3a and C5a anaphylatoxins: specific increase in interleukin-6 mRNA expression.
    Sayah S; Ischenko AM; Zhakhov A; Bonnard AS; Fontaine M
    J Neurochem; 1999 Jun; 72(6):2426-36. PubMed ID: 10349852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Signaling by hemolytically inactive C5b67, an agonist of polymorphonuclear leukocytes.
    Wang C; Gerard NP; Nicholson-Weller A
    J Immunol; 1996 Jan; 156(2):786-92. PubMed ID: 8543834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C3a activates reactive oxygen radical species production and intracellular calcium transients in human eosinophils.
    Elsner J; Oppermann M; Czech W; Dobos G; Schöpf E; Norgauer J; Kapp A
    Eur J Immunol; 1994 Mar; 24(3):518-22. PubMed ID: 8125125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a.
    Van Epps DE; Simpson SJ; Johnson R
    J Immunol; 1993 Jan; 150(1):246-52. PubMed ID: 8417126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis-toxin-sensitive G protein.
    Norgauer J; Dobos G; Kownatzki E; Dahinden C; Burger R; Kupper R; Gierschik P
    Eur J Biochem; 1993 Oct; 217(1):289-94. PubMed ID: 8223566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement c3a and c5a induce different signal transduction cascades in endothelial cells.
    Schraufstatter IU; Trieu K; Sikora L; Sriramarao P; DiScipio R
    J Immunol; 2002 Aug; 169(4):2102-10. PubMed ID: 12165538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
    Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
    J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
    Fukuoka Y; Ember JA; Hugli TE
    J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective hexapeptide agonists and antagonists for human complement C3a receptor.
    Scully CC; Blakeney JS; Singh R; Hoang HN; Abbenante G; Reid RC; Fairlie DP
    J Med Chem; 2010 Jul; 53(13):4938-48. PubMed ID: 20527893
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human C5a modulates monocyte Fc and C3 receptor expression.
    Yancey KB; O'Shea J; Chused T; Brown E; Takahashi T; Frank MM; Lawley TJ
    J Immunol; 1985 Jul; 135(1):465-70. PubMed ID: 3158706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
    Laumonnier Y; Karsten CM; Köhl G; Köhl J
    Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
    Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
    Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand-induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by "G protein-coupled receptor kinases.
    Langkabel P; Zwirner J; Oppermann M
    Eur J Immunol; 1999 Sep; 29(9):3035-46. PubMed ID: 10508278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C3a receptor antagonist SB 290157 has agonist activity.
    Mathieu MC; Sawyer N; Greig GM; Hamel M; Kargman S; Ducharme Y; Lau CK; Friesen RW; O'Neill GP; Gervais FG; Therien AG
    Immunol Lett; 2005 Sep; 100(2):139-45. PubMed ID: 16154494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-function studies of the C3a-receptor: C-terminal serine and threonine residues which influence receptor internalization and signaling.
    Settmacher B; Rheinheimer C; Hamacher H; Ames RS; Wise A; Jenkinson L; Bock D; Schaefer M; Köhl J; Klos A
    Eur J Immunol; 2003 Apr; 33(4):920-7. PubMed ID: 12672058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Signaling through C5aR is not involved in basal neurogenesis.
    Bogestål YR; Barnum SR; Smith PL; Mattisson V; Pekny M; Pekna M
    J Neurosci Res; 2007 Oct; 85(13):2892-7. PubMed ID: 17551982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mouse anaphylatoxin C3a receptor: molecular cloning, genomic organization, and functional expression.
    Tornetta MA; Foley JJ; Sarau HM; Ames RS
    J Immunol; 1997 Jun; 158(11):5277-82. PubMed ID: 9164946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modulation of monocyte chemotactic function in inflammatory lesions. Role of inflammatory mediators.
    Katona IM; Ohura K; Allen JB; Wahl LM; Chenoweth DE; Wahl SM
    J Immunol; 1991 Jan; 146(2):708-14. PubMed ID: 1898961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.